Zacks Investment Research on MSN
Here's why you should retain Masimo stock in your portfolio now
Masimo Corporation MASI is well-poised for growth in the coming quarters, courtesy of its strong underlying demand for ...
Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ...
Zacks Investment Research on MSN
Masimo stock declines despite solid preliminary Q4 revenues
Masimo Corporation MASI announced preliminary revenues for the fourth quarter and full year 2025 on Monday. Despite the ...
The Irvine-based medical device maker expects Q4 revenue to increase 12% to $411 million and full year revenue to grow 9% to $1.5 billion.
Mixed bag of news for Apple as Masimo tumbles in quality despite patent win, on-device AI threatens data centers, and the Tim Cook-led company scales back Vision Pro production.
Masimo reported positive Q4 results. However, investors weren't happy with the company's plan to acquire Sound United. The concerns center on whether Sound United, a consumer tech company, is a good ...
(Reuters) -Masimo said on Thursday that it is prepared to appoint Politan Capital Management's nominee William Jellison as a director on its board, if the activist investor withdraws its other nominee ...
(Reuters) -Masimo said on Wednesday founder Joe Kiani has decided to step down as the medical device maker's CEO, days after shareholders voted to remove him from the company's board following a ...
Masimo (Nasdaq: MASI) is a global technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, ...
Masimo (NASDAQ:MASI) supports medical monitoring innovation as nasdaq composite discussions include healthcare technology ...
Masimo (MASI) is back in focus after recent trading left the shares around US$138.92, with returns that differ sharply across time frames, from a small move over the past month to a deeper decline ...
Masimo CEO shared confidential information with investor ahead of public release, court filing shows
Masimo CEO Joe Kiani, whose medical-technology company is in the midst of a proxy battle with activist Politan, revealed what he called confidential information to a major investor 12 hours before it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results